C19) United States C12) Patent Application Publication C10) Pub

C19) United States C12) Patent Application Publication C10) Pub

1111111111111111 IIIIII IIIII 1111111111 11111 11111 111111111111111 1111111111 1111111111 11111111 US 20200081016Al c19) United States c12) Patent Application Publication c10) Pub. No.: US 2020/0081016 Al Talaat et al. (43) Pub. Date: Mar. 12, 2020 (54) BIOMARKERS FOR EARLY DIAGNOSIS Publication Classification AND DIFFERENTIATION OF (51) Int. Cl. MYCOBACTERIAL INFECTION GOIN 33/68 (2006.01) C12Q 116851 (2006.01) (71) Applicant: Wisconsin Alumni Research GOIN 33/569 (2006.01) Foundation, Madison, WI (US) (52) U.S. Cl. (72) Inventors: Adel Mohamed Talaat, Madison, WI CPC ......... GOIN 33/6854 (2013.01); GOIN 33/68 (US); Chia-wei Wu, Madison, WI (US) (2013.01); GOIN 2800/50 (2013.01); GOIN 33/5695 (2013.01); GOIN 2800/26 (2013.01); (21) Appl. No.: 16/555,819 C12Q 116851 (2013.01) (22) Filed: Aug. 29, 2019 (57) ABSTRACT Mycobacterial-specific biomarkers and methods of using Related U.S. Application Data such biomarkers for diagnosis of mycobacterial infection in (60) Provisional application No. 62/728,387, filed on Sep. a mammal are disclosed. 7, 2018. Specification includes a Sequence Listing. Patent Application Publication Mar. 12, 2020 Sheet 1 of 10 US 2020/0081016 Al FIG. 1 ·~{:: -{t i * !lpNbiNi$ 1 !lpN p~ra 111:111111 llillllll: 111!11,111llltllllll~ 11111 ■111 ~; C,,Nmnsus KR.IGINMTKX L.lC(X.AXXXXG AXXXXMPXTX RXO-GXVXXVG VKVXPWIPTX ® • ® l I I iipN lK>V(S ~Hl!lli!Wiofflij 1!11.llofJiillj mllB~lijftlt flol=fiolill ••t-il-~MM ~9 llpN p~ra HfHJoffit:torti ilffllGNillm miJllt~ttiollf ~•01:101111 llm:l:l1IA@~ iOO C,,nstmsus XXRXLXXGRS Vt IOGNT.LDP i LOt.MLSXXR XXGXOG.I...XVO ODXXXSR:AXM t2:;: i-/4~~ ! l 1 I~~~~b;:: llllil~l:1:1 llil 111111:1~:111~ 1111111::;1 1lllilllll: ~:~ C,,nimnsus XXXXXXXPGP QtHVDVXXI...X XPGPAGXIPA RHYRPXGGXX QXPt.l...VFYHG Consl:lrvat,ofl -:§;::. .{;;-:;: 2-/4{~ ! -: lipN Mvlii ■,Htl\ilftffl 80~1;01ffl\il Gtlij!~Got!lt mHMBll~III @111:aommmi 248 !ipN pam ltWAHfb.rn;o ·I ffioA!.lffioffitAll ooiffAGGfdMi #WlttiAII# · · -, ·GGffiASI 245 C<m$0rn,us XWAHEHA.XOE .XGAXPGRVAV GGOSAGGNLX AVVKQLAROX AR:YEGGPXPV :1::K> ~~=~<~ ! j !lpN b<1Vi$ llllilRllil.ffiB ijofj~ffiiRl.li:I AoBft!tlffilBo iililiillti omAl:18111:s 348 UpN pm;;i IIIW:iillill AalAiilRII AGl!l!iiiilG ffi!iiii~DIAA ot:m1:111111~ 345 CMBl:lf';Bus R:XSPXLAE$L XGLAPAt I AV AGFDPI...RDEG XSYAXALRAA GTXVOtRYLG :E:, :m::, ~ ~ 1ipN b<1vis illibislIIHII ffilGoGiKAGI ililli*RIIH iill 3~ tipN pm;;i i!lfi.GiAi!II i!IGGlii~jij!f il.lffl!jijfflffii{ij iiil'iJi 3W CMBMS!JS SI... THGFXNLF QI...GGXSXXXT· XE.l I SAL RAH I...SRV Patent Application Publication Mar. 12, 2020 Sheet 2 of 10 US 2020/0081016 Al FIGS. 2A-2B A. 1 Q Ii N B. 3 Patent Application Publication Mar. 12, 2020 Sheet 3 of 10 US 2020/0081016 Al ... <l) ,;,: Ct1 c:; (I) > Y'J 2 (lJ i::: 'O (.) tlj .::- ...(I) Q,, 0 0 >- ~ d. ·o"' @ ·o 0 ~ E 0 § ,c:. .. u 0 C <ti Q) 2 C) S? 6 ..,-, 0 9. ·- FIGS. 4A-4C ""O ~..... ('D =..... A B t"e Infected vs. LAV­ .... LAV-vaccinated vs. (')- Infected vs, na!'ve na'ive Infected vs. naYve vaccinated ~......... 0= =""O O".... (')- ~......... 0= ~ ~ :-:.... N ~ Total analyzed genes: 17,380 Total analyzed genes: 17,380 N 0 N 0 rJ'1 ('D=­ LAV~vaccinated vs, Mycopar-vaccinated ('D..... naive vs. nalve .i;... 0 C .... 0 c rJ'1 N 0 N 0 0 0--- QO.... 0.... 0-1 Total analyzed genes: 17,380 >.... Patent Application Publication Mar. 12, 2020 Sheet 5 of 10 US 2020/0081016 Al mrnrnrnmmmmmi . rnrnmrnmmmmllllllll irnrnrnmrnmrnrnmm. rn;;mrnrnmrnmm1l!!!!!!I ~~~~~~~~~~~~~~~~~~~~~~tttt~~~ttttr . rnrnmrnrnmmmmmmm. .Mllltllllltlllttt\t\t\t\t\] mmmrnmrnmmmmmmm . ili~~~~~~~~~~~~~~~~~~~~~~~~~~rrr~~ttt~tttt rnmrnmmmmmmmmmmmi rnmmmmmmmmrnmmmmm rnmmrnmmmmmmmmmmmmmm wmmmmmmmmmmmmmmmm mmmmmmmmmmmmmmmm rnmmmrnmmmmmmmmmmmmmmmm rnmmmmmmmmmmmmmrnmmrnmmi rnmmmmmmmmmmmmmmmmmm@ 0 0 2v< :.o Patent Application Publication Mar. 12, 2020 Sheet 6 of 10 US 2020/0081016 Al FIGS. 6A-6B A !'~:':~:Rrn3t:~ ..,./''(~·· ·.,::::::;,:::::fR~CG ·~-:>' B ,r \\,,\ ;•OMES ,~, CZMA G---.""'":...~ ~ ;:....,.)WNC - -.,; ...•. l'. :::'·:t2:.'.;::.~~···••······ .. ··········· .:1~=· :ajffe:f . ,•;,;• ~r&;,,,.·•····························· ¼:]y' Patent Application Publication Mar. 12, 2020 Sheet 7 of 10 US 2020/0081016 Al ~ r;~~ ~r-u-, d~ ~----,_,.,.,.,.,.,.,.;, ' --C~i l. .•.•.•.•.•.•.•.•.•.•.•.•.•'.•.•.•.•.•.•.•.•.•.•.•.•.•-'•.•.•.•.•.•.•.•.•.•.•.•.•.•'.•.•.•.•.•.•.•.•.•.•.•.•.•-~•-•.•.•.•.•.•.•.•.•.•.•.•.•'-•-•.•.•.•.•.•.•.•.•.•.•.•.•I g ~ g C ~ 1 ~ Patent Application Publication Mar. 12, 2020 Sheet 8 of 10 US 2020/0081016 Al UHH&lllllllllllllllllllllM: : : : : rnmmmmmmmmmmmmrnmmmn BWiff:i\UWHH\UWHUiWWHH\UiHH} MP;{N%J:iNi!JNJ:iHNihh:fN%J:iNk %MHMMbbbbbbbbbt@ : : : : : rnrnrnrnmmmmmmmmmmmmrn : mmmmmmmmmmmmmmmmrn. : : : : mmmmmmmmmmmmmmmmrn rnrnmrnmmmmmmmmmmmmmrn C..) 00 rnrnrnrnrnrnmmmmmmmmmmmrn ~ : : : : : : 00 r:/) rnmmmmmmmmmmmwmmmmmmmmmrn d : : : : : : . -f..l.; rnrnrnrnrnrnrnmmmmmmmmmmmrn . rnmmmmmmmmmmmmmmmmmmt' . HH9HHH#iU%<HfotkHHMHH#Hk rnrnmrnrnmrnwmmmmmmmmmrnmmmn {MMinh%JhHh%%%JN%%§hhHhHhHhNk tfiUf!f}fiUfidfhfdifH!U!fdiU!ifHidfdifHiU!ifHifHiU!if}!idiU!ifHifHifi '. : i:i:i:i:i:::i:i:i:i:i:i:i:i:i:i:::i:i:i:i:i:i:i:i:i:i::i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:i:::i:i:i:i:i:i:i:i:i:i:::i:i:i:i:i:i:i:i:i:i:i l~~~~~~~~~~~~~~~~I~~~~~III{IIII{IIIII~IIIIIIIIIIIJIIII{IIIII! mmmmmmmmmmmmmmmmmmmmmmmmmmt . : : : . : : . mmmrnmmmmmmmmmmmm1mmmmmmmmmm: 0 Patent Application Publication Mar. 12, 2020 Sheet 9 of 10 US 2020/0081016 Al :mmmmmmmmmrnmmmm@ rnmmmmmrnmmmmmmm: mmmrnmmmmmmmmmmmmrn mrnmmrnmmmmmmmmmmm: rnmmmmmmmmmmmmmmrn rnmmmmmmmmmmmmmmrn rnmmmmmmmmmmmwmmmmm@ Cl -µl rnmrnrnrnrnrnmmmmmmmmmrn ;::::iz r< rnrnrnrnrnmmmmmmmmmmmmm - Q.! ,? Bu (Q mmmmmmrnmmmmmmmmmmmmmrn '--' z u !.n : itttttttttii:ittttti:tttttii:ittttti 00 > I !It~IIIII~IIIIIIIIII{IIIII~IIIII{IIIII! <!; ~-~ 00 \.) (Q u-i > mmmmmmmmmrrnrnrnrnrnrnrnrnrn 0 < -f,J.; ~____, rnmmmmmrnrnrnrnrnrnrnrnrnrnrnrnt mmmmmmrnmmmmmm;;rnmmmmmrn @mmmmmmmmmmmmmrnmmmmmrn ummmmmmmmmmmmmmmmmmmmmmrn wetsx+wr+vngugugugugugugugugugugugu;ngugugugu;s : : : : : : m~~~~~~~~~~~~~~~~~~~~~~~~~~ttt~tttttttttttttttt~~ttttttttttt~ttttl mmmmmrnmmmmmmmm;;mmm;;mmmmmmm;mmmmimmrn rnmmmmtmrnmmmmmmmmmmmmmwmmmmm: 0 c, C.1 rl ~ Percent of genes • f·.:>. ..... (,.>.; +' -:.. n o~, -....J ()") \.!,_} () 0 b "'0 0 0 0 0 0 0 0 0 <'"v,..···,(, ·<7/(-.: .., \.~~.. ~:{ A. '-"','l) '(,<. 9::'.,{:', ·{,,'I',,_.,_ l'J,; •. 6.-, ··-···v/· ., ,,., (,,,i. 'f✓/ ,:;>"' =rnmmmmrnmmmmmMrnrnMmmmmrn@rnrnrnmrn '/.··:.::, 'O.,... 'O,. '"'%, o,.~,,~, ':0,/:·~,:, «,:;,·.,,. <,,.,. .. /<~~// .. '•q_.::} i>.,, '<.>'/., '~'1.,, ,..{;:,.. b,. ,.-;>,,, q,. =~ (((' l◊/- "(\-~ ..~.; c/A . ·;!~-,. ,;, ;,, . •,.;. rniiiiiiimrnimmiiiiiii1iiiiiiim1ii~~t~t~rnnmmmmrn -...y,v.· --<.-:.~~'.· ·r.¾:.. .. _ ~--:.l, '<>'/ ··%>,,, ' ,::'.';,-◊.-. '•~.:::◊. '··<:\-. >"~---· ,.zh>.<. ,:),;:<c;,~::;-;:~s "'lj 2i' >-< ··:y''\;, ?1..:., '-,.,- (") a if; = (") . "/Jo,,. ·-<,.N. Ci <>;,.. ' <"'.,, '-"'.-\i~, 0 ·/.-7.,. C/, .......,,, •'", -:.::: 00 rs;, ·t·;.:::,;, ·r:>r--;.,,_. ·-·.•v,..__ ·- '.,.(} >I :::s <·(.-:,;) .. 'o ' '?---. ...... 00 :.,:,s ·,:'/. •. ::<.,:;:,., ' <..}(< .. ~\ 0 --+, (') ..... 0<·1\,,..),;, '(;,-;.~:,/_ \,. fD rs;, rnmmmmrnmmmmmmrnHrnHt@ (') ·-;>.t-:.,. /~.. = rt­ n -o' ..t~.,,- ',7¼·~,,. '°::<\ m ~ ,,:;\;;,,..,... "'f.'-\-❖.1. ' .,,. rnmmmmmimmmmmmmmmmmt 0... •< i.. ~ ~ <>ft.,, ··-~,;,<, z 9°':),1.;. ''-...>t C .. {.~-::. ...... ,.,~:o,.o m <;-'/} ... /_...<.,,.. ... .._..0 ·,;:-7,_> . ·,.),. C't, ,< r.(<,. ·,.,) • ,•'>._ •• 'O' --~s :\.-. .. ,.1:'r. h(. ~ "<:..1/ ,,,. ''o.-. , <~~, ... <_.~.;.-<-•;..-, -~...-...;t. .. rnmmmmmmmmmmmmmumatrn ·)"_... = .-:::-;, . ,✓,.(< <Y"' z:;::;?r., /· <':-X,h ~,~(..:.,.-:: ·.;. :~~rrrrrrrrrrrrrrrrrrrrrrrr~~~~~~~~~t~ ◊.r-, '\,.,,, ·~·.•<->'(>,._ '">'.J;, ...../G!l, .. -:o.,... <:;-:,t :;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;&t~t~t~t~t~t~mm@ .-.. ;,-~/,~ ' ·,:..{:.~:-. //___),. y_ ~'('• ... ...... : >.•j:Y~:::-- </1~ "' '✓-:·;;,/ • •:iiiiiiiiiiiiiiiiiiiiiiliiii1111111rnrnmmrnrn• ..-?,;:~-, ...<~~·p . :-.}Q....... '-lq.-:~ >-...-.-::~, ,I •rnmmmmm;mmmm1rnm1rn • "b,.. ) Vf<::,'~.,. rnmmmmmmmmmmmmmm IV 9IOI800/0ZOZ Sil OI JO OI J.l.lQS ozoz 'n "Jtrw UO!JRJ!{qlld UO!JRJ!{ddy JU.lJRd US 2020/0081016 Al Mar. 12, 2020 1 BIOMARKERS FOR EARLY DIAGNOSIS tionally, needed in the art are methods or diagnostic tools for AND DIFFERENTIATION OF distinguishing vaccinated from infected animals. MYCOBACTERIAL INFECTION SUMMARY OF THE INVENTION CROSS-REFERENCE TO RELATED [0009] The present invention overcomes the aforemen­ APPLICATIONS tioned drawbacks by providing a set of biomarkers to [0001] This application claims priority to U.S. Provisional diagnose infected animals and distinguishing between vac­ Patent Application No. 62/728,387 filed Sep. 7, 2018, which cinated and infected animals. is incorporated herein in its entirety. [0010] In a first aspect, provided herein is a method for diagnosis of mycobacterial infection in a mammal, the STATEMENT REGARDING FEDERALLY method comprising the steps of a) obtaining a first type of SPONSORED RESEARCH sample from the mammal; b) measuring the expression level in the sample of at least one biomarker selected from the [0002] This invention was made with govermnent support group consisting of LOC108634521, LOC108637251, under 2013-67015-21347, 2018-67015-28243 and 2016- LOC108637252, LOC108634594, FAM198B, 33610-25438 awarded by the USDA/NIFA. The government LOC108637671, CDCPl, TMTCl, BAIAP2Ll, MEIi, has certain rights in the invention. SEPTl0, IFNG, IL17F, FCER2, ADGRGl, APBBl, PIWIL2, AOAH, and homologs thereof and comparing the REFERENCE TO A SEQUENCE LISTING level

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    45 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us